CDX
SK-MEL-5
Tumor indication
Skin
Tumor subtype
Malignant Melanoma
Description
SK-MEL-5 (Melanoma CDX Model)
The SK-MEL-5 line was derived from a metastatic melanoma lesion. It carries the BRAF V600E mutation, a common driver in melanoma. SK-MEL-5 has been extensively applied in targeted therapy development. Its reproducible growth ensures reliability in translational melanoma research.
Key Features:
- Derived from metastatic melanoma.
- BRAF V600E mutation.
- Strong MAPK pathway activation.
- Reliable xenograft tumorigenicity.
Applications:
SK-MEL-5 is used in drug discovery targeting BRAF and MEK pathways. Researchers employ it in biomarker validation and resistance mechanism studies. It is a standard melanoma model for preclinical targeted therapy testing. Its defined genetics make it suitable for precision oncology pipelines.
Details
- Tumor indication
- Skin
- Tumor subtype
- Malignant Melanoma
- Organism
- Human
- Mouse sex
- Female
- Lumin data
- Proteomics, RNA-Seq, WES
Mutated genes
Select a gene to see the variants recorded for this line.
Gene expression
Show all values
| Gene | Expression |
|---|
Expression measured across the Champions panel.
Lumin data
Request this cell line
Let's build the right study, together.
Backed by deep expertise in these models, our team will work with you to design the study around your target, line of therapy, and endpoint.